• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表面基质筛选鉴定出能提高近泛 HIV-1 中和抗体效力的半特异性相互作用。

Surface-Matrix Screening Identifies Semi-specific Interactions that Improve Potency of a Near Pan-reactive HIV-1-Neutralizing Antibody.

机构信息

Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD 20892, USA.

Department of Pathology and Cell Biology, Columbia University, New York, NY 10032, USA.

出版信息

Cell Rep. 2018 Feb 13;22(7):1798-1809. doi: 10.1016/j.celrep.2018.01.023.

DOI:10.1016/j.celrep.2018.01.023
PMID:29444432
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5889116/
Abstract

Highly effective HIV-1-neutralizing antibodies could have utility in the prevention or treatment of HIV-1 infection. To improve the potency of 10E8, an antibody capable of near pan-HIV-1 neutralization, we engineered 10E8-surface mutants and screened for improved neutralization. Variants with the largest functional enhancements involved the addition of hydrophobic or positively charged residues, which were positioned to interact with viral membrane lipids or viral glycan-sialic acids, respectively. In both cases, the site of improvement was spatially separated from the region of antibody mediating molecular contact with the protein component of the antigen, thereby improving peripheral semi-specific interactions while maintaining unmodified dominant contacts responsible for broad recognition. The optimized 10E8 antibody, with mutations to phenylalanine and arginine, retained the extraordinary breadth of 10E8 but with ∼10-fold increased potency. We propose surface-matrix screening as a general method to improve antibodies, with improved semi-specific interactions between antibody and antigen enabling increased potency without compromising breadth.

摘要

高效的 HIV-1 中和抗体在 HIV-1 感染的预防或治疗中可能具有实用性。为了提高 10E8 的效力,10E8 是一种能够近乎广谱中和 HIV-1 的抗体,我们对其表面突变体进行了工程改造,并筛选出具有改善中和作用的变体。功能增强最大的变体涉及添加疏水性或带正电荷的残基,这些残基分别定位于与病毒膜脂质或病毒糖基唾液酸相互作用。在这两种情况下,改进的部位与抗体介导与抗原蛋白成分分子接触的区域在空间上分离,从而改善外周半特异性相互作用,同时保持负责广泛识别的未修饰主要接触。经过苯丙氨酸和精氨酸突变优化的 10E8 抗体保留了 10E8 的非凡广度,但效力提高了约 10 倍。我们提出表面基质筛选作为一种通用的抗体改进方法,抗体与抗原之间改善的半特异性相互作用使效力提高而不损害广度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10d0/5889116/9c9fcd22ee82/nihms943901f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10d0/5889116/9ccf9e9d2c3b/nihms943901f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10d0/5889116/e00273ebbf6c/nihms943901f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10d0/5889116/b3a362c3a3b6/nihms943901f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10d0/5889116/858bc97efc0c/nihms943901f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10d0/5889116/c05b6639f133/nihms943901f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10d0/5889116/397adec6c066/nihms943901f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10d0/5889116/9c9fcd22ee82/nihms943901f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10d0/5889116/9ccf9e9d2c3b/nihms943901f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10d0/5889116/e00273ebbf6c/nihms943901f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10d0/5889116/b3a362c3a3b6/nihms943901f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10d0/5889116/858bc97efc0c/nihms943901f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10d0/5889116/c05b6639f133/nihms943901f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10d0/5889116/397adec6c066/nihms943901f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10d0/5889116/9c9fcd22ee82/nihms943901f7.jpg

相似文献

1
Surface-Matrix Screening Identifies Semi-specific Interactions that Improve Potency of a Near Pan-reactive HIV-1-Neutralizing Antibody.表面基质筛选鉴定出能提高近泛 HIV-1 中和抗体效力的半特异性相互作用。
Cell Rep. 2018 Feb 13;22(7):1798-1809. doi: 10.1016/j.celrep.2018.01.023.
2
Functional Optimization of Broadly Neutralizing HIV-1 Antibody 10E8 by Promotion of Membrane Interactions.通过促进膜相互作用对广泛中和性HIV-1抗体10E8进行功能优化
J Virol. 2018 Mar 28;92(8). doi: 10.1128/JVI.02249-17. Print 2018 Apr 15.
3
Optimization of the Solubility of HIV-1-Neutralizing Antibody 10E8 through Somatic Variation and Structure-Based Design.通过体细胞变异和基于结构的设计优化HIV-1中和抗体10E8的溶解度
J Virol. 2016 Jun 10;90(13):5899-5914. doi: 10.1128/JVI.03246-15. Print 2016 Jul 1.
4
Mechanism of HIV-1 neutralization by antibodies targeting a membrane-proximal region of gp41.针对 gp41 膜近端区域的抗体对 HIV-1 的中和作用机制。
J Virol. 2014 Jan;88(2):1249-58. doi: 10.1128/JVI.02664-13. Epub 2013 Nov 13.
5
Enhancing HIV-1 Neutralization by Increasing the Local Concentration of Membrane-Proximal External Region-Directed Broadly Neutralizing Antibodies.通过增加膜近端外部区域导向的广谱中和抗体的局部浓度来增强 HIV-1 中和作用。
J Virol. 2023 Jan 31;97(1):e0164722. doi: 10.1128/jvi.01647-22. Epub 2022 Dec 21.
6
Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency.抗V3/聚糖和抗膜近端外部区域(MPER)中和抗体,而非抗V2/聚糖位点抗体,与更强的抗HIV-1中和广度和效力密切相关。
J Virol. 2015 May;89(10):5264-75. doi: 10.1128/JVI.00129-15. Epub 2015 Feb 11.
7
Lipid interactions and angle of approach to the HIV-1 viral membrane of broadly neutralizing antibody 10E8: Insights for vaccine and therapeutic design.广泛中和抗体10E8与HIV-1病毒膜的脂质相互作用及接近角度:对疫苗和治疗设计的启示
PLoS Pathog. 2017 Feb 22;13(2):e1006212. doi: 10.1371/journal.ppat.1006212. eCollection 2017 Feb.
8
Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape.一种通过病毒逃逸导致膜近端外部区域(MPER)暴露的新型HIV-1 gp120-gp41界面抗体的结构与识别
PLoS Pathog. 2017 Jan 11;13(1):e1006074. doi: 10.1371/journal.ppat.1006074. eCollection 2017 Jan.
9
Exposure of the HIV-1 broadly neutralizing antibody 10E8 MPER epitope on the membrane surface by gp41 transmembrane domain scaffolds.gp41 跨膜结构域支架使 HIV-1 广谱中和抗体 10E8 MPER 表位暴露在膜表面。
Biochim Biophys Acta Biomembr. 2018 Jun;1860(6):1259-1271. doi: 10.1016/j.bbamem.2018.02.019. Epub 2018 Feb 23.
10
Effect of diversity in gp41 membrane proximal external region of primary HIV-1 Indian subtype C sequences on interaction with broadly neutralizing antibodies 4E10 and 10E8.原发性 HIV-1 印度 C 亚型 gp41 膜近端外部区多样性对与广泛中和抗体 4E10 和 10E8 相互作用的影响。
Virus Res. 2019 Nov;273:197763. doi: 10.1016/j.virusres.2019.197763. Epub 2019 Sep 22.

引用本文的文献

1
Defining criteria for broadly neutralizing HIV antibodies.定义广泛中和HIV抗体的标准。
Front Immunol. 2025 Jul 17;16:1624020. doi: 10.3389/fimmu.2025.1624020. eCollection 2025.
2
Transient glycan shield reduction induces CD4-binding site broadly neutralizing antibodies in SHIV-infected macaques.短暂的聚糖屏蔽减少在感染SHIV的猕猴中诱导出结合CD4位点的广谱中和抗体。
Cell Rep. 2025 Jun 24;44(6):115848. doi: 10.1016/j.celrep.2025.115848. Epub 2025 Jun 13.
3
Distinctive Membrane Accommodation Traits Underpinning the Neutralization Activity of HIV-1 Antibody against MPER.

本文引用的文献

1
Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques.三特异性广泛中和HIV抗体在猕猴中介导对猿猴免疫缺陷病毒的有效保护。
Science. 2017 Oct 6;358(6359):85-90. doi: 10.1126/science.aan8630. Epub 2017 Sep 20.
2
Potent and broad HIV-neutralizing antibodies in memory B cells and plasma.记忆B细胞和血浆中强效且广谱的HIV中和抗体。
Sci Immunol. 2017 Jan 27;2(7). doi: 10.1126/sciimmunol.aal2200.
3
Lipid interactions and angle of approach to the HIV-1 viral membrane of broadly neutralizing antibody 10E8: Insights for vaccine and therapeutic design.
支持HIV-1抗体对跨膜区的中和活性的独特膜适应特性。
Mol Pharm. 2025 May 5;22(5):2494-2508. doi: 10.1021/acs.molpharmaceut.4c01341. Epub 2025 Apr 9.
4
Ab initio prediction of specific phospholipid complexes and membrane association of HIV-1 MPER antibodies by multi-scale simulations.通过多尺度模拟对HIV-1 MPER抗体的特定磷脂复合物和膜结合进行从头预测。
Elife. 2025 Apr 7;12:RP90139. doi: 10.7554/eLife.90139.
5
Engineering of CD8 T cells with an HIV-specific synthetic notch receptor to secrete broadly therapeutic antibodies for combining antiviral humoral and cellular immune responses.利用HIV特异性合成Notch受体对CD8 T细胞进行工程改造,以分泌具有广泛治疗作用的抗体,从而联合抗病毒体液免疫和细胞免疫反应。
mBio. 2025 Apr 9;16(4):e0383924. doi: 10.1128/mbio.03839-24. Epub 2025 Feb 25.
6
Structural development of the HIV-1 apex-directed PGT145-PGDM1400 antibody lineage.HIV-1顶端导向的PGT145-PGDM1400抗体谱系的结构发育
Cell Rep. 2025 Jan 28;44(1):115223. doi: 10.1016/j.celrep.2024.115223. Epub 2025 Jan 17.
7
Generation of a Nonbilayer Lipid Nanoenvironment after Epitope Binding Potentiates Neutralizing HIV-1 MPER Antibody.表位结合后产生非双层脂质纳米环境可增强中和 HIV-1 MPER 抗体。
ACS Appl Mater Interfaces. 2024 Nov 6;16(44):59934-59948. doi: 10.1021/acsami.4c13353. Epub 2024 Oct 24.
8
Design of soluble HIV-1 envelope trimers free of covalent gp120-gp41 bonds with prevalent native-like conformation.设计不含共价 gp120-gp41 键的可溶性 HIV-1 包膜三聚体,具有流行的天然样构象。
Cell Rep. 2024 Aug 27;43(8):114518. doi: 10.1016/j.celrep.2024.114518. Epub 2024 Jul 18.
9
Cholesterol reduction by immunization with a PCSK9 mimic.通过免疫接种 PCSK9 模拟物降低胆固醇。
Cell Rep. 2024 Jun 25;43(6):114285. doi: 10.1016/j.celrep.2024.114285. Epub 2024 May 30.
10
Phase 1 trial evaluating safety and pharmacokinetics of HIV-1 broadly neutralizing mAbs 10E8VLS and VRC07-523LS.评估 HIV-1 广泛中和单克隆抗体 10E8VLS 和 VRC07-523LS 安全性和药代动力学的 1 期临床试验。
JCI Insight. 2024 Apr 8;9(7):e175375. doi: 10.1172/jci.insight.175375.
广泛中和抗体10E8与HIV-1病毒膜的脂质相互作用及接近角度:对疫苗和治疗设计的启示
PLoS Pathog. 2017 Feb 22;13(2):e1006212. doi: 10.1371/journal.ppat.1006212. eCollection 2017 Feb.
4
Peripheral Membrane Interactions Boost the Engagement by an Anti-HIV-1 Broadly Neutralizing Antibody.外周膜相互作用增强了一种抗HIV-1广谱中和抗体的结合能力。
J Biol Chem. 2017 Mar 31;292(13):5571-5583. doi: 10.1074/jbc.M117.775429. Epub 2017 Feb 17.
5
Antibody 10-1074 suppresses viremia in HIV-1-infected individuals.抗体10-1074可抑制HIV-1感染个体的病毒血症。
Nat Med. 2017 Feb;23(2):185-191. doi: 10.1038/nm.4268. Epub 2017 Jan 16.
6
Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape.一种通过病毒逃逸导致膜近端外部区域(MPER)暴露的新型HIV-1 gp120-gp41界面抗体的结构与识别
PLoS Pathog. 2017 Jan 11;13(1):e1006074. doi: 10.1371/journal.ppat.1006074. eCollection 2017 Jan.
7
Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption.HIV抗体VRC01对治疗中断后病毒反弹的影响。
N Engl J Med. 2016 Nov 24;375(21):2037-2050. doi: 10.1056/NEJMoa1608243. Epub 2016 Nov 9.
8
Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth.鉴定一种对HIV具有近泛中和广度的CD4结合位点抗体。
Immunity. 2016 Nov 15;45(5):1108-1121. doi: 10.1016/j.immuni.2016.10.027.
9
Coming-of-Age of Antibodies in Cancer Therapeutics.抗体在癌症治疗中的成熟之路。
Trends Pharmacol Sci. 2016 Dec;37(12):1009-1028. doi: 10.1016/j.tips.2016.09.005. Epub 2016 Oct 10.
10
Polyarginine Interacts More Strongly and Cooperatively than Polylysine with Phospholipid Bilayers.与磷脂双层相比,聚精氨酸比聚赖氨酸具有更强且更协同的相互作用。
J Phys Chem B. 2016 Sep 8;120(35):9287-96. doi: 10.1021/acs.jpcb.6b05604. Epub 2016 Aug 29.